Going Public

The Mountain View, Calif.-based sequencing-as-a-service company Complete Genomics "plans to sell up to an estimated $86.3 million in an initial public offering," according to the Wall Street Journal, and is "staking its claim to the ticker symbol GNOM" on the Nasdaq, the San Jose Mercury News reports.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.